Warberg Asset Management’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Warberg Asset Management’s Portfolio TCBPW Stock Details TCBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-86,667	Closed	-$10.9K	–	293
2022 Q4	$10.9K	Hold	86,667	–	–	﹤0.01%	201
2022 Q3	$11K	Hold	86,667	–	–	﹤0.01%	232
2022 Q2	$18K	Sell	86,667 -1,600	-2%	-$502	﹤0.01%	187
2022 Q1	$44K	Buy	+88,267	New	+$41K	0.01%	166

Other funds holding TCBPW

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Warberg Asset Management's TCBPW Position: Q1 2023 in Review

Warberg Asset Management sold out of TC BioPharm (Holdings) plc Warrants (TCBPW) in Q1 2023, closing a stake of 86,667 shares — an estimated $10.9K sold.

Warberg Asset Management first reported a position in TCBPW in Q1 2022 and held it in 4 quarters. The position peaked at $44K in Q1 2022. 5 funds tracked by Wall St. Rank hold TCBPW as of Q1 2023.

Warberg Asset Management reported no remaining TC BioPharm (Holdings) plc Warrants position as of Q1 2023 after selling out during the quarter.
Warberg Asset Management sold 86,667 TC BioPharm (Holdings) plc Warrants shares in Q1 2023, an estimated $10.9K.
Warberg Asset Management first reported a position in TC BioPharm (Holdings) plc Warrants in Q1 2022 and held it in 4 quarters.
Warberg Asset Management's TC BioPharm (Holdings) plc Warrants position peaked at $44K in Q1 2022.
5 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q1 2023.

Based on Warberg Asset Management's 13F filing for Q1 2023, filed 15 May 2023.